Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】



News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】

FDA approves Takeda’s Alunbrig (brigatinib) as a new first-line treatment option for ALK

FDA approves Takeda’s Alunbrig (brigatinib) as a new first-line treatment option for ALK

2025-10-19 11:44:20

CAMBRIDGE, Mass. and OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceuticals, Inc. today announced that the U.S.

Check Details

FDA approves Takeda's Alunbrig (brigatinib) for the treatment of crizotinib-resistant ALK-positive metastatic non-small cell lung cancer_Canghule

2025-10-19 11:44:20

Check Details

1
2
...
10202
10203
10204
10205
10206
10207
10208
10209
10210
10211

Category

相关知识